Thus, we identified several novel genes, and demonstrated the clinical relevance of CCL8 as a candidate marker for the diagnosis and prognosis of IPF patients for the first time to the best of our knowledge. This evidence concerns the gene CCL8 and idiopathic pulmonary fibrosis.